Co-crystal E-58425
AssetAlso E-58425, Tramadol/Celecoxib
Co-crystal of tramadol and celecoxib providing dual opioid and anti-inflammatory analgesia via COX-2 and mu-opioid receptor modulation
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- Inflammation
- 1
- Indication
- 382
- Trials
- 1
- Developer
Indications
1Acute post surgical pain
Phase 3, Completed, NCT03108482, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains6
- Owner and partners1
- Trials382
- Evidence for its targets6
- Competitors12
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.